Käyhty et al., 1980 - Google Patents
Serum antibodies to capsular polysaccharide vaccine of group A Neisseria meningitidis followed for three years in infants and childrenKäyhty et al., 1980
- Document ID
- 16725562745067176746
- Author
- Käyhty H
- Karanko V
- Peltola H
- Sarna S
- Mäkelä P
- Publication year
- Publication venue
- Journal of Infectious Diseases
External Links
Snippet
The persistence of antibodies to the capsular polysaccharide of group A Neisseria meningitidis was studied in 2,030 persons vaccinated at the age of 10 weeks to 19 years and followed for three years. Both the initial antibody response and the persistence of …
- 102000004965 antibodies 0 title abstract description 92
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Käyhty et al. | Serum antibodies to capsular polysaccharide vaccine of group A Neisseria meningitidis followed for three years in infants and children | |
| Powers et al. | Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults | |
| Murphy et al. | Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens | |
| Anderson et al. | Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b | |
| EP0301992B1 (en) | Vaccine against group B Neisseria meningitidis, gammaglobulin and transfer factor | |
| Lepow et al. | Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children | |
| Challacombe | Serum and salivary antibodies to Streptococcus mutans in relation to the development and treatment of human dental caries | |
| Ceesay et al. | Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization | |
| Borrow et al. | Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults | |
| McCormick et al. | Antibody response to serogroup A and C meningococcal polysaccharide vaccines in infants born of mothers vaccinated during pregnancy. | |
| Borrow et al. | Induction of immunological memory in UK infants by a meningococcal A/C conjugate vaccine | |
| Henderson et al. | Long-lasting, specific immunologic unresponsiveness associated with cryptococcal meningitis. | |
| Sanchez et al. | Safety and immunogenicity of the oral, whole cell/recombinant B subunit cholera vaccine in North American volunteers | |
| Hazlewood et al. | The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK | |
| Frasch et al. | Antibody response of adults to an aluminum hydroxide-adsorbed Neisseria meningitidis serotype 2b protein-group B polysaccharide vaccine | |
| Loeb et al. | Human antibody response to individual outer membrane proteins of Haemophilus influenzae type b | |
| Rosenqvist et al. | Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection | |
| Pomat et al. | Immunoglobulin G antibody responses to polyvalent pneumococcal vaccine in children in the highlands of Papua New Guinea | |
| Robin et al. | Characterization and quantitative analysis of serum IgG class and subclass response to Shigella sonnei and Shigella flexneri 2a lipopolysaccharide following natural Shigella infection | |
| O’Neil et al. | Basidiospore extracts: evidence for common antigenic/allergenic determinants | |
| Longworth et al. | Avidity maturation following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine in UK infants | |
| Van De Verg et al. | Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection | |
| Käyhty et al. | Immunogenicity of Haemophilus influenzae oligosaccharide-protein and polysaccharide-protein conjugate vaccination of children at 4, 6, and 14 months of age | |
| Gregory et al. | Salivary immunoglobulin A and serum antibodies to Streptococcus mutans ribosomal preparations in dental caries-free and caries-susceptible human subjects | |
| Wasserman et al. | Kinetics of the vibriocidal antibody response to live oral cholera vaccines |